Weight Loss

Semaglutide

Semaglutide is an injectable peptide that is a GLP-1 (glucagon-like peptide-1) agonist. GLP-1 is the hormone which plays a major role in appetite and digestion. It also slows down how quickly food leaves your stomach (called gastric emptying). Semaglutide also stimulates your pancreas to release more insulin and blocks a hormone in the liver which releases sugar. As a result, these actions cause you to feel fuller longer, eat less, and lose weight.

Tirzepatide

Tirzepatide is an injectable peptide that is a GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) agonist that works within the stomach, it works on two receptor sites. GLP-1 and GIP are both incretin hormones, which are released after eating. Tirzepatide acts like two incretins, therefore, it can cause more weight loss.

Contraindications for Semaglutide and Tirzepatide include:

Personal or Family History of Thyroid Cancer
Type 1 Diabetes
History of Pancreatitis
History of Multiple Endocrine Neoplasia Syndrome type 2
Pregnant or Breastfeeding

Side Effects of Semaglutide or Tirzepatide

Nausea
Indigestion
Vomiting
Diarrhea
Constipation
Localized Reaction at injection site

Medication Information

Michele NP only sources the safest available medications for patient use. She is credentialed with 503b FDA outsourcing manufacturers for Semaglutide which contains no vitamin or salt additives, and is the closest to brand in potency and consistency.

Michele NP is a credentialed provider with multiple large scale compound pharmacies in multiple states authorized to compound injectable medications while on the FDA shortage list for Tirzepatide,

Please be advised medications purchased on-line without a prescription are considered research chemicals and are considered unsafe for human use.